Role of iron metabolism and oxidative damage in postmenopausal bone loss

Bone

Volumn 43, Issue 6, 2008, Pages 1010-1015

  D'Amelio, Patrizia ^a   Cristofaro, Maria A ^a   Tamone, Cristina ^a   Morra, Emanuella ^b   Di Bella, Stefania ^a   Isaia, Gianluca ^a   Grimaldi, Anastasia ^a   Gennero, Luisa ^a,b   Gariboldi, Angela ^c   Ponzetto, Antonio ^a,b   Pescarmona, Gian Piero ^b   Isaia, Giovanni Carlo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CERM   (Italy)

^c Laboratorio Analisi Baldi e Riberi   (Italy)

Author keywords

Bone density; Haptoglobin; Iron; Osteoporosis; Oxidized LDL

Indexed keywords

BIOLOGICAL MARKER; HAPTOGLOBIN; IRON; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE INJURY; BONE MASS; BONE METABOLISM; CONTROLLED STUDY; FEMALE; FRAGILITY FRACTURE; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; LIPID OXIDATION; MAJOR CLINICAL STUDY; OSTEOLYSIS; OXIDATIVE STRESS; PHENOTYPE; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS;

AGED; BLOTTING, WESTERN; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRON; LIPOPROTEINS, LDL; MIDDLE AGED; OSTEOPOROSIS; OXIDATIVE STRESS; POSTMENOPAUSE; RISK FACTORS;

EID: 57149118441     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.08.107     Document Type: Article

References (26)

1. Tussing L., and Chapman-Novakofski K. Osteoporosis prevention education: behavior theories and calcium intake. J. Am. Diet. Assoc. 105 (2005) 92-97
2. Isaia G., D'Amelio P., Di Bella S., and Tamone C. Protein intake: the impact on calcium and bone homeostasis. J. Endocrinol. Invest. 30 (2007) 48-53
3. Ryan P., and Dixon T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway. Curr. Med. Res. Opin. 22 (2006) 211-216
4. Cashman K.D. Diet, nutrition, and bone health. J. Nutr. 137 (2007) 2507S-2512S
5. Palacios C. The role of nutrients in bone health, from A to Z. Crit. Rev. Food Sci. Nutr. 46 (2006) 621-628
6. Katsumata S., Tsuboi R., Uehara M., and Suzuki K. Dietary iron deficiency decreases serum osteocalcin concentration and bone mineral density in rats. Biosci. Biotechnol. Biochem. 70 (2006) 2547-2550
7. Medeiros D.M., Plattner A., Jennings D., and Stoecker B. Bone morphology, strength and density are compromised in iron-deficient rats and exacerbated by calcium restriction. J. Nutr. 132 (2002) 3135-3141
8. Parelman M., Stoecker B., Baker A., and Medeiros D. Iron restriction negatively affects bone in female rats and mineralization of hFOB osteoblast cells. Exp. Biol. Med. (Maywood) 231 (2006) 378-386
9. Ilich-Ernst J.Z., McKenna A.A., Badenhop N.E., Clairmont A.C., Andon M.B., Nahhas R.W., et al. Iron status, menarche, and calcium supplementation in adolescent girls. Am. J. Clin. Nutr. 68 (1998) 880-887
10. Altindag O., Erel O., Soran N., Celik H., and Selek S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol. Int. 28 (2008) 317-321
11. Yousefzadeh G., Larijani B., Mohammadirad A., Heshmat R., Dehghan G., Rahimi R., et al. Determination of oxidative stress status and concentration of TGF-beta 1 in the blood and saliva of osteoporotic subjects. Ann. N. Y. Acad. Sci. 1091 (2006) 142-150
12. Jialal I., and Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin. Chem. 42 (1996) 498-506
13. Delanghe J.R., Langlois M.R., Boelaert J.R., Van Acker J., Van Wanzeele F., van der Groen G., et al. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. Aids 12 (1998) 1027-1032
14. Langlois M.R., and Delanghe J.R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42 (1996) 1589-1600
15. Camejo G., Halberg C., Manschik-Lundin A., Hurt-Camejo E., Rosengren B., Olsson H., et al. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J. Lipid Res. 39 (1998) 755-766
16. Tseng C.F., Lin C.C., Huang H.Y., Liu H.C., and Mao S.J. Antioxidant role of human haptoglobin. Proteomics 4 (2004) 2221-2228
17. Brouwers A., Langlois M., Delanghe J., Billiet J., De Buyzere M., Vercaemst R., et al. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 176 (2004) 189-195
18. Cox S.E., Doherty C., Atkinson S.H., Nweneka C.V., Fulford A.J., Ghattas H., et al. Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection. PLoS. ONE 2 (2007) e362
19. Levy A.P., Roguin A., Hochberg I., Herer P., Marsh S., Nakhoul F.M., et al. Haptoglobin phenotype and vascular complications in patients with diabetes. N. Engl. J. Med. 343 (2000) 969-970
20. Burbea Z., Nakhoul F., Zoabi R., Hochberg I., Levy N.S., Benchetrit S., et al. Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients. Ann. Clin. Biochem. 41 (2004) 469-473
21. Kanis J.A. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos. Int. 4 (1994) 368-381
22. Pescarmona G.P., D'Amelio P., Morra E., and Isaia G.C. Haptoglobin genotype as a risk factor for postmenopausal osteoporosis. J. Med. Genet. 38 (2001) 636-638
23. Sanchez-Rodriguez M.A., Ruiz-Ramos M., Correa-Munoz E., and Mendoza-Nunez V.M. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC. Musculoskelet. Disord. 8 (2007) 124
24. D'Amelio P., Rossi P., Isaia G., Lollino N., Castoldi F., Girardo M., et al. Bone mineral density and singh index predict bone mechanical properties of human femur. Connect. Tissue Res. 49 (2008) 99-104
25. Sato K., Nohtomi K., Demura H., Takeuchi A., Kobayashi T., Kazama J., et al. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone 21 (1997) 57-64
26. Grundberg E., Lau E.M., Pastinen T., Kindmark A., Nilsson O., Ljunggren O., et al. Vitamin D receptor 3′ haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS study in Sweden and Hong Kong. J. Bone Miner. Res. (2007)